Target intelligence / Profile preview

RNA, U6 small nuclear 4, pseudogene (RNU6-4P)

Target
RNU6-4P
Molecular classification
Other (Pseudogene, small nuclear RNA-related)
01

Overview

RNU6-4P represents a non-functional copy (pseudogene) derived from the gene encoding U6 small nuclear RNA (snRNA), which is an essential component of the spliceosome, the cellular machinery responsible for removing introns from pre-mRNA in eukaryotes[6][3][1]. While the canonical U6 snRNA is highly conserved and critical for splicing chemistry, catalytic activity, and nucleotide modification events within the nucleus[1][4], pseudogenes such as RNU6-4P are abundant in the genome but lack known biological activity or protein products[6]. As such, RNU6-4P does not serve as a therapeutic target and has no direct role in disease, drug interactions, or biomarker status. The entry may be misleading if used as a molecular target for drug discovery or functional genomics. Additional context: - The functional U6 snRNA gene has numerous pseudogene copies in vertebrate genomes, further emphasizing its evolutionary significance but also the genomic prevalence of inactive variants[3]. - For any therapeutic, molecular, or biomarker applications, only the functional U6 snRNA (not RNU6-4P) is relevant; the pseudogene itself is ignored in experimental and clinical settings. - The pseudogene designation (RNU6-4P) indicates lack of transcriptional activity or functional RNA/protein product[6].

Other names
U6-4RNU6-4RNU6-4P

Beyond the preview

Go deeper on RNA, U6 small nuclear 4, pseudogene (RNU6-4P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 4, pseudogene (RNU6-4P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call